Autoantibodies against neurofascin, contactin1, or contactin-associated protein 1 (Caspr) occur in approximately 10% of chronic inflammatory demyelinating polyneuropathy (CIDP) patients. This evidence concerns the gene NFASC and chronic inflammatory demyelinating polyradiculoneuropathy.